BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 4154764)

  • 21. Effects of beta-adrenoceptor blocking agents, pindolol, alprenolol and practolol on blood pressure and heart rate in conscious renal hypertensive dogs.
    Himori N; Ishimori T; Izumi A; Hiramatsu Y
    Arch Int Pharmacodyn Ther; 1977 Jan; 225(1):152-65. PubMed ID: 15525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Some metabolic effects of metipranolol, propranolol, alprenolol, oxprenolol, and practolol in rats.
    Siblíková O; Trcka V
    Acta Univ Carol Med (Praha); 1980; 26(5-6):259-70. PubMed ID: 6126105
    [No Abstract]   [Full Text] [Related]  

  • 23. A comparative study of the activity of beta-adrenoceptor antagonists in man.
    Taylor SH; Thadani U; Davidson C; singleton W; Myint S
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):305-6. PubMed ID: 240783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade.
    McDevitt DG; Brown HC; Carruthers SG; Shanks RG
    Clin Pharmacol Ther; 1977 May; 21(5):556-66. PubMed ID: 15753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Structure-activity relationship of phenoxyalkanolamine derivatives with selective beta 1-receptor blocking action].
    Femmer K
    Pharmazie; 1975 Oct; 30(10):638-42. PubMed ID: 687
    [No Abstract]   [Full Text] [Related]  

  • 26. Proceedings: Combined effects of Lb46 resp. practolol and histamine on parameters of respiration and circulation in guinea pigs.
    Kilian U; Dittmann EC
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R47. PubMed ID: 4152364
    [No Abstract]   [Full Text] [Related]  

  • 27. Nitrilophenoxypropanolamines: influence of ring substitution on beta-receptor blockade.
    Mylecharane EJ; Raper C
    Eur J Pharmacol; 1974 Nov; 29(1):93-101. PubMed ID: 4154862
    [No Abstract]   [Full Text] [Related]  

  • 28. [Action of various beta adrenolytic agents on the alpha blocking properties of yohimbine in the dog].
    Mouillé P; Cheymol G
    C R Seances Soc Biol Fil; 1973; 167(3):440-2. PubMed ID: 4150410
    [No Abstract]   [Full Text] [Related]  

  • 29. Heart rate after combined vagal and sympathetic blockade with atropine and different beta-receptor blocking agents.
    Fenyvesi T; Káldor A; Sebestyén K
    Int J Clin Pharmacol; 1973 Nov; 8(3):254-7. PubMed ID: 4149237
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties.
    Weber MA; Stokes GS; Gain JM
    J Clin Invest; 1974 Dec; 54(6):1413-9. PubMed ID: 4154950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac action of carazolol and methypranol in comparison with other beta-receptor blockers.
    Bartsch W; Dietmann K; Leinert H; Sponer G
    Arzneimittelforschung; 1977; 27(5):1022-6. PubMed ID: 18157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical aspects of the anti-arrhythmic actions of beta-receptor blocking drugs. 2. Clinical pharmacology.
    Singh BN
    N Z Med J; 1973 Dec; 78(505):529-35. PubMed ID: 4150209
    [No Abstract]   [Full Text] [Related]  

  • 33. [Comparative study of chronotropic and inotropic effects of different beta adrenolytic drugs].
    Cheymol G; Mouillé P; Laubie M; Schmitt H
    C R Seances Soc Biol Fil; 1972; 166(6):823-8. PubMed ID: 4143908
    [No Abstract]   [Full Text] [Related]  

  • 34. [Comparative study on the effects of alprenolol, bunitrolol, ethaverine, oxprenolol, papaverine, practolol, pindolol, pronethalol, propranolol, toliprolol and verapamil on cardiac and bronchial beta-receptors (author's transl)].
    Wuppermann D; Zimmermann F; Friedrich L
    Arzneimittelforschung; 1978; 28(5):794-8. PubMed ID: 35172
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man.
    Gibson DG
    Drugs; 1974; 7(1):8-38. PubMed ID: 4151693
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacological studies on 1-(7-indenyloxy)-3-isopropylaminopropan-2-Ol hydrochloride (YB-2), a new -adrenergic blocking agent.
    Tachikawa S; Takenaka T
    Arch Int Pharmacodyn Ther; 1973 Mar; 202(1):79-92. PubMed ID: 4144371
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of several beta-blockers on blood pressure in the rat.
    Yamamoto J; Sekiya A; Maekawa H
    Jpn J Pharmacol; 1975 Aug; 25(4):465-71. PubMed ID: 1562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent.
    Miyagishi A; Nakahara H; Hara Y
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):249-62. PubMed ID: 6210068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative effects of several beta-adrenergic inhibitors on pulmonary resistance in guinea pigs].
    Giudicelli JF; Boissier JR; Dumas Y; Advenier C
    C R Seances Soc Biol Fil; 1973; 167(2):232-7. PubMed ID: 4153959
    [No Abstract]   [Full Text] [Related]  

  • 40. Selective beta blockade of isolated rabbit detrusor muscle with practolol (AY21,011) and N-isopropylmethoxamine.
    Anderson GF; Kreulen DL; Fredericks CM
    Arch Int Pharmacodyn Ther; 1973 Oct; 205(2):373-80. PubMed ID: 4148834
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.